Energy metabolism transition in multi-cellular human tumor spheroids

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 189-197

  Rodríguez Enríquez, Sara ^a   Gallardo Pérez, Juan Carlos ^a   Avilés Salas, Alejandro ^b   Marín Hernández, Alvaro ^a   Carreño Fuentes, Liliana ^a   Maldonado Lagunas, Vilma ^b   Moreno Sánchez, Rafael ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; DEOXYGLUCOSE; GOSSYPOL; HEXOKINASE; RHODAMINE 123; CASIOPEINA II GLYCINE; CASIOPEINA II-GLYCINE; FLUORESCENT DYE; LACTONE; LAHERRADURIN; ORGANOMETALLIC COMPOUND; OXYGEN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; GLYCOLYSIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; MONOLAYER CULTURE; MULTICELLULAR SPHEROID; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR GROWTH; TUMOR SPHEROID; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; DEOXYGLUCOSE; ENERGY METABOLISM; FLUORESCENT DYES; GLYCOLYSIS; GOSSYPOL; HUMANS; LACTONES; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OXIDATIVE PHOSPHORYLATION; OXYGEN; RHODAMINE 123; SPHEROIDS, CELLULAR;

EID: 44449149325     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21392     Document Type: Article

References (80)

1. Acker H, Carlsson J, Holterman G, Nederman T, Nylen T. 1987. Influence of glucose and buffer capacity in the culture medium on growth and pH in spheroids of human thyroid carcinoma and human glioma origin. Cancer Res 47:3504-3508.
2. Acker H, Holtermann G, Bolling B, Carlsson J. 1992. Influence of glucose on metabolism and growth of rat glioma cells (C6) in multicellular spheroid culture. Int J Cancer 52:279-285.
3. An WG, Kanekal M, Simon MC, Maltepec E, Blagosklonny MV, Neckers LM. 1998. Stabilization of wild-type p53 by hypoxia-inducible factor 1 alpha. Nature 392:405-408.
4. Bergmeyer HU. 1974. Methods of enzymatic analysis. Weinheim: Verlag Chemie.
5. Bourrat-Floeck B, Groebe K, Mueller-Klieser W. 1991. Biological response of multicellular EMT6 spheroids to exogenous lactate. Int J Cancer 47:792-799.
6. Brandt U, Okun JG. 1997. Role of deprotonation events in ubihydroquinone: Cytochrome c reductase from bovine heart and yeast mitochondria. Biochemistry 36:11234-11240.
7. Brautigan DJ, Ferguson-Miller S, Margoliash E. 1978. Mitochondrial cytochrome c: Preparation and activity of native and chemically modified cytochromes c. Methods Enzymol 53:128-164.
8. Bredel-Geissler A, Karbach U, Walenta S, Vollrath L, Mueller-Klieser W. 1992. Proliferation-associated oxygen consumption and morphology of tumor cells in monolayer and spheroid culture. J Cell Physiol 153:44-52.
9. Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ. 2005. Influence of in vivo growth on human glioma cell line gene expression: Convergent profiles under orthotopic conditions. Proc Natl Acad Sci USA 102:8287-8292.
10. Carlsson J, Acker H. 1988. Relations between pH, oxygen partial pressure and growth in cultured cell spheroids. Int J Cancer 42:715-720.
11. Carlsson J, Yuhas JM. 1984. Liquid-overlay culture of cellular spheroids. Cancer Res 95:1-23.
12. Coller HA, Sang L, Roberts JM. 2006. A new description of cellular quiescence. PloS Biol 4:e83.
13. Dang CV, Semenza GL. 1999. Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72.
14. Dang CV, Lewis BC, Dolde C, Dang G, Shim H. 1997. Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J Bioenerg Biomembr 29:345-354.
15. Freyer JP. 1988a. Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res 48:2432-2439.
16. Freyer JP. 1988b. Partial purification of a protein growth inhibitor from multicellular spheroids. J Cell Physiol 176:138-149.
17. Freyer JP, Sutherland RM. 1985. A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol 124:516-524.
18. Freyer JP, Sutherland RM. 1986. Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply. Cancer Res 46:3513-3520.
19. Freyer JP, Tustanoff E, Franko AJ, Sutherland RM. 1984. In situ oxygen consumption rates of cells in V-79 multicellular spheroids during growth. J Cell Physiol 118:53-61.
20. Freyer JP, Schor PL. Jarret KA, Neeman M, Sillerud LO. 1991. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Cancer Res 51:3831-3837.
21. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. 1998. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 201:1129-1139.
22. González-Coloma A, Guadano A, de Inés C, Martínez-Diaz R, Cortés D. 2002. Selective action of acetogenin mitochondrial complex I inhibitors. Z Naturforsch 57:1028-1034.
23. Gorlach A, Acker H. 1994. pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227:105-112.
24. Guppy M, Leedman P, Zu X, Russell V. 2002. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364:309-315.
25. Hand S, Carpenter J. 1986. pH-induced hysteretic properties of phosphofructokinase purified from rat myocardium. Am J Physiol 250:R505-R511.
26. 2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes. Biochem J 227:129-136.
27. Hauptmann S, Gebauer-Hartung P, Leclere A, Denkert C, Pest S, Klosterhalfen B, Diatel M. 1998. Induction of apoptosis in the centre of multicellular tumour spheroids of colorectal adenocarcinomas - Involvement of CD95 pathway and differentiation. Apoptosis 3:267-279.
28. Hu CJ, Wang LY, Chodosh LA, Keith B. Simon MC. 2003. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374.
29. Hystad ME, Rofstad EK. 1994. Oxygen consumption rate and mitochondrial density in human melanoma monolayer cultures and multicellular spheroids. Int J Cancer 57:532-537.
30. Kashiwagura T, Deutsch CJ, Taylor J, Erecinska M, Wilson DF. 1984. Dependence of gluconeogenesis, urea synthesis, and energy metabolism of hepatocytes on intracellular pH. J Biol Chem 259:237-243.
31. Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. 2003. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotech Bioeng 83:173-180.
32. Khaitan D, Chandna S, Arya MB, Dwarakanath BS. 2006. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 4:12.
33. Kim JW, Tchernyshyov I, Semenza GL. Dang CV. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:150-151.
34. Kunz-Schughart LA, Doetsch J, Muller-Klieser W, Groebe K. 2000. Proliferative activity and tumorigenic conversion: Impact on cellular metabolism in 3-D culture. Am J Physiol Cell Physiol 278:C765-C780.
35. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. 2004. The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J Biomol Screen 9:273-285.
36. Kunz-Shughart LA, Habbersett RC, Freyer JP. 2001. Impact of proliferative activity and tumorigenic conversion on mitochondrial function of fibroblasts in 2D and 3D culture. Cell Biol Int 25:919-930.
37. Lampidis TJ, Bernal SD, Summerhayes IC, Chen LB. 1983. Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res 43:716-720.
38. Leek RD, Stratford I, Harris AL. 2005. The role of hypoxia-inducible factor-1 in three-dimensional tumor growth, apoptosis, and regulation by the insulin-signaling pathway. Cancer Res 65:4147-4152.
39. Marín-Hernández A, Gracia-Mora I, Ruiz-Ramírez L, Moreno-Sánchez R. 2003. Toxic effects of copper-based antineoplastic drugs (Casiopeinas) on mitochondrial functions. Biochem Pharmacol 65:1979-1989.
40. Marín-Hernández A, Rodríguez-Enríquez S, Vital-González PA, Flores-Rodríguez FL, Macías-Silva M, Sosa-Garrocho M, Moreno-Sánchez R. 2006. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an overexpressed but strongly product-inhibited hexokinase. FEBS J 273:1975-1988.
41. Mathupala S, Heese C, Pedersen PL. 1997. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem 272:22776-22780.
42. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. 2006. p53 regulates mitochondrial respiration. Science 312:1650-1653.
43. Melo RF, Stevan FR, Campello AP, Carnieri EG, de Oliveira MB. 1998. Occurrence of the Crabtree effect in HeLa cells. Cell Biochem 16:99-105.
44. Miccoli L, Oudard S, Sureau F, Poirson F, Dutrillaux B, Poupon MF. 1996. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. BiochemJ 313:957-962.
45. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. 2007. Energy metabolism in tumor cells. FEBSJ 274:1393-1418.
46. Mueller-Klieser W, Freyer JP, Sutherland RM. 1986. Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br J Cancer 53:345-353.
47. Murphy BJ, Laderoute VR, Vreman HJ, Grant TD, Gill NS, Stevenson DK, Sutherland RM. 1993. Enhancement of heme oxygenase expression and activity in A431 squamous carcinoma multicellular tumor spheroids. Cancer Res 53:2700-2703.
48. Nakashima RA, Paggi MG, Pedersen PL. 1984. Contributions of glycolysis and oxidatve phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells. Cancer Res 44:5702-5706.
49. Olive PL, Durand RE. 1985. Effect of intercellular contact on DNA conformation, radiation-induced DNA damage, and mutation in Chinese hamster V79 cells. Radiat Res 101:94-101.
50. Pavelic K, Slaus NP, Spaventi R. 1991. Growth factors and proto-oncogenes in early mouse embryogenesis and tumorigenesis. Int J Dev Biol 35:209-214.
51. Pecina P, Gnaiger E, Zeman J, Pronicka E, Houstek T. 2004. Decreased affinity for oxygen of cytochrome-c oxidase in Leigh syndrome caused by SURFI mutations. Am J Physiol Cell Physiol 287:C1384-C1388.
52. Pouysségur J, Sardet C, Franchi A, L'Allemain G, Paris S. 1984. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblast precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81:4833-4837.
53. Qian SZ, Wang ZG. 1984. Gossypol: A potential antifertility agent for males. Annu Rev Pharmacol Toxicol 24:329-360.
54. Reitzer LJ, Wice BM, Kennell D. 1979. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 254:2669-2676.
55. Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ. 2005. Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7:324-330.
56. Rodríguez-Enríquez S, Juárez O, Rodríguez- Zavala JS, Moreno-Sánchez R. 2001. Multisite control of the Crabtree effect in ascites hepatoma cells. Eur J Biochem 268:2512-2519.
57. Rodríguez-Enríquez S, Flores-Rodríguez FL, Vital-González PA, Marín-Hernández A, Ruiz-Azuara L, Moreno-Sánchez R. 2006a. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol Appl Pharmacol 215:208-217.
58. Rodríguez-Enríquez S, Kim I, Currin RT. Lemasters JJ. 2006b. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2:39-46.
59. Ronen SM, Rushkin E, Degani H. 1991. Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta 1095:5-16.
60. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA. 2004. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64:985-993.
61. Royds JA, Dower SK, Qwarnstrom EE, Lewis CE. 1998. Response of tumour cells to hypoxia: Role of p53 and NFkB. Mol Pathol 51:55-61.
62. Schwacha A, Bell SP. 2001. Interactions between two catalytically distinct MCM subgroups are essential for coordinated ATP hydrolysis and DNA replication. Mol Cell 8:1093-1104.
63. Stahl A, Frick A. 1978. Enzymic micro-assay for blood glutamine. Clin Chem 24:1730-1733.
64. Stubbs M, Bashford CL, Griffiths JR. 2003. Understanding the tumor metabolic phenotype in the genomic era. Curr Mol Med 3:49-59.
65. Sumner JB. 1964. A method for the colorimetric determination of phosphorus. Science 100:413-414.
66. Sutherland RM. 1988. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240:177-184.
67. Sweet S, Singh G. 1995. Accumulation of human promyelocyte leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res 55:5164-5167.
68. Vaupel P, Schaefer C. 1994. Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed 7:128-136.
69. Vaupel P, Kallinowski F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
70. von Wangenheim KH, Peterson HP. 1998. Control of cell proliferation by progress in differentiation: Clues to mechanisms of aging, cancer causation and therapy. J Theor Biol 193:663-678.
71. Walenta S, Dotsch J, Mueller-Klieser W. 1990. ATP concentrations in multicellular tumor spheroids assessed by single photon imaging and quantitative bioluminescence. Eur J Cell Biol 52:389-393.
72. Walenta S, Dotsch J, Mueller-Klieser W, Kunz-Schughart LA. 2000. Metabolic imaging in multicellular spheroids of oncogene-transfected fibroblasts. J Histochem Cytochem 48:509-522.
73. Walenta S, Feigk B, Wachsmuth I, Dunkern T, Degani H, Muller-Klieser W. 2002. Differential changes in purine nucleotides after doxorubicin treatment of human cancer cells in vitro. Int J Oncol 21:289-296.
74. Warburg O. 1956. On the origin of cancer cells. Science 123:309-314.
75. Weber G. 2001. Ordered biochemical program of gene expression in cancer cells. Biochemistry (Mosc) 66:1164-1173.
76. Wu FJ, Friend JR, Remmel RP, Cerra FB, Hu WS. 1999. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant 8:233-246.
77. Xu R, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P. 2005. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65:613-621.
78. Yu LJ, Matias J, Scudiero DA, Hite KM, Monks A, Sausville EA, Waxman DJ. 2001. P450 enzyme expression patterns in the NCl human tumor cell line panel. Drug Metab Dispos 29:304-312.
79. Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z. 2003. Impairment of human ether-à-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem 278:10417-10426.
80. Zu XL, Guppy M. 2004. Cancer metabolism: Facts, fantasy, and fiction. Biochem Biophys Res Commun 313:459-465.